Evidence map›Paper›PMID 30048543›Full record

ArticlePloS one2018

Catabolism of mucus components influences motility of Vibrio cholerae in the presence of environmental reservoirs.

Geethika Reddi, Kali Pruss, Kathryn L Cottingham, Ronald K Taylor, Salvador Almagro-Moreno

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Allelic variations and gene cluster modularity act as nonlinear bottlenecks for cholera emergence.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Review
  6. Public health aspects ofEFSA journal. European Food Safety Authority · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Cholera Dynamics and the Emergence of Pandemic Vibrio cholerae.Advances in experimental medicine and biology · 2023
    Article
  11. Intestinal colonization againstAIMS microbiology · 2023
    Review
  12. Vibrio Infections and the Twenty-First Century.Advances in experimental medicine and biology · 2023
    Article
  13. Review
  14. Review
  15. Ecological diversification reveals routes of pathogen emergence in endemicProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  16. Microbial genomics · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Geethika ReddiBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida, United States of America.
Kali PrussDepartment of Microbiology & Immunology, Stanford School of Medicine, Stanford University, Palo Alto, California, United States of America.
Kathryn L CottinghamDepartment of Biological Sciences, Dartmouth College, Hanover, New Hampshire, United States of America.
Ronald K TaylorDepartment of Microbiology and Immunology, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire, United States of America.
Salvador Almagro-MorenoBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida, United States of America.ORCID 0000-0002-1121-1204
Dartmouth College · USUniversity of Central Florida · USStanford University · US

Funding

GENTICS DETERMINATION OF VIRULENCE OF VIBRIO CHOLERAER01AI025096 · NIAID · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI SKORUPSKI, KAREN A · 1989 to 2016
$3.1M
NIAID NIH HHS R01 AI025096
6 · The paper itself

Abstract

Vibrio cholerae O1, the etiological agent of cholera, is a natural inhabitant of aquatic ecosystems. Motility is a critical element for the colonization of both the human host and its environmental reservoirs. In this study, we investigated the molecular mechanisms underlying the chemotactic response of V. cholerae in the presence of some of its environmental reservoirs. We found that, from the several oligosaccharides found in mucin, two specifically triggered motility of V. cholerae O1: N-acetylneuraminic acid (Neu5Ac) and N-acetylglucosamine (GlcNAc). We determined that the compounds need to be internally catabolized in order to trigger motility of V. cholerae. Interestingly, the catabolism of Neu5Ac and GlcNAc converges and the production of one molecule common to both pathways, glucosamine-6-phosphate (GlcN-6P), is essential to induce motility in the presence of both compounds. Mutants unable to produce GlcN-6P show greatly reduced motility towards mucin. Furthermore, we determined that the production of GlcN-6P is necessary to induce motility of V. cholerae in the presence of some of its environmental reservoirs such as crustaceans or cyanobacteria, revealing a molecular link between the two distinct modes of the complex life cycle of V. cholerae. Finally, cross-species comparisons revealed varied chemotactic responses towards mucin, GlcNAc, and Neu5Ac for environmental (non-pathogenic) strains of V. cholerae, clinical and environmental isolates of the human pathogens Vibrio vulnificus and Vibrio parahaemolyticus, and fish and squid isolates of the symbiotic bacterium Vibrio fischeri. The data presented here suggest nuance in convergent strategies across species of the same bacterial family for motility towards suitable substrates for colonization.

Indexed as

AcetylglucosamineAnimalsChemotaxisCholeraCrustaceaCyanobacteriaHost-Pathogen InteractionsHumansMetabolic Networks and PathwaysMucusN-Acetylneuraminic AcidVibrio choleraeVibrio cholerae O1AcetylglucosamineN-Acetylneuraminic Acid

Identifiers

PMID30048543
PMCPMC6062102
OpenAlexW2883128787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.